Quantinno Capital Management’s Novo Nordisk NVO Stock Holding History

Quantinno Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.4M	Buy	593,206 +241,514	+69%	+$10.4M	0.03%	579
2026 Q1	$12.9M	Buy	351,692 +33,006	+10%	+$1.56M	0.02%	765
2025 Q4	$16.2M	Buy	318,686 +51,390	+19%	+$2.63M	0.03%	599
2025 Q3	$14.8M	Buy	267,296 +21,856	+9%	+$1.28M	0.04%	505
2025 Q2	$16.9M	Buy	245,440 +8,393	+4%	+$571K	0.07%	317
2025 Q1	$16.5M	Buy	237,047 +25,181	+12%	+$2.08M	0.11%	198
2024 Q4	$18.2M	Buy	211,866 +9,885	+5%	+$1.07M	0.18%	73
2024 Q3	$24M	Buy	201,981 +16,995	+9%	+$2.27M	0.31%	42
2024 Q2	$26.4M	Buy	184,986 +64,769	+54%	+$8.58M	0.47%	27
2024 Q1	$15.4M	Buy	120,217 +3,793	+3%	+$452K	0.34%	43
2023 Q4	$12M	Sell	116,424 -4,985	-4%	-$493K	0.42%	28
2023 Q3	$11M	Buy	121,409 +80,195	+195%	+$7.06M	0.5%	25
2023 Q2	$3.33M	Buy	41,214 +4,386	+12%	+$358K	0.19%	90
2023 Q1	$2.93M	Buy	36,828 +6,624	+22%	+$470K	0.19%	99
2022 Q4	$2.04M	Buy	30,204 +13,944	+86%	+$818K	0.15%	183
2022 Q3	$810K	Buy	16,260 +11,706	+257%	+$627K	0.1%	251
2022 Q2	$254K	Buy	+4,554	New	+$253K	0.04%	506

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Quantinno Capital Management's NVO Position: Q2 2026 in Review

Quantinno Capital Management increased its Novo Nordisk (NVO) stake by 69% in Q2 2026, buying an estimated $10.4M and bringing the position to 593,206 shares worth $28.4M. The position accounts for 0.03% of the portfolio, ranked #579.

Quantinno Capital Management first reported a position in NVO in Q2 2022 and has held it in 17 quarters since. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Quantinno Capital Management held 593,206 shares of Novo Nordisk worth $28.4M as of Q2 2026.
Quantinno Capital Management bought 241,514 Novo Nordisk shares in Q2 2026, an estimated $10.4M.
Novo Nordisk made up 0.03% of Quantinno Capital Management's portfolio in Q2 2026, its #579 holding.
Quantinno Capital Management first reported a position in Novo Nordisk in Q2 2022 and has held it in 17 quarters since.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.